Seizure 23 (2014) 397–398

Contents lists available at ScienceDirect

Seizure journal homepage:

Clinical letter

Lacosamide in absence status epilepticus Giuseppe d’Orsi *, Francesca Pacillo, Marina Trivisano, Maria Grazia Pascarella, Maria Angela Ferrara, Luigi M. Specchio Epilepsy Center – Clinic of Nervous System Diseases, University of Foggia, Riuniti Hospital, Foggia, Italy


Article history: Received 5 September 2013 Received in revised form 30 November 2013 Accepted 2 December 2013

To the Editor Although Lacosamide (LCM) has become a widely used drug in patients with status epilepticus,1 the role of LCM in patients with idiopathic generalized epilepsy presenting with absence status epilepticus (ASE) is currently unknown. A 57-year-old woman came to be under our observation after experiencing confusion and drowsiness, immediately after waking up. Her family history was unremarkable. Apart from mild mental retardation and epilepsy, she had no other medical problems. Rare tonic-clonic seizures, and episodes of lost contact lasting for a few seconds or minutes had occurred monthly since the age of 6 years old despite having been treated with 2000 mg/ day valproate (VPA), 300 mg/day lamotrigine (LTG), 3000 mg/day levetiracetam (LEV), 300 mg/day topiramate, 100 mg/day phenobarbital. The interictal EEG showed generalized spike-wave and polyspike-wave discharges at 3–4 Hz, lasting from 1 to 3 s. Brain MRI and genetic analysis (karyotype and array-CGH) were normal. After 6 h from the onset of confusion, the patient was admitted to our centre and at that time she was on 2000 mg/day VPA (plasma VPA was 87 mg/L, range 50–100 mg/L) and 3000 mg/day LEV (plasma LEV was 25 mg/L, range 10–37 mg/ L). A long-term video-EEG monitoring was performed and ASE was diagnosed. In particular, she was slow, vague, inattentive, with no verbal contact and displayed rare, small myoclonic twitches of the eyelids and facial muscles. The ictal EEG revealed a continuous, generalized, 2.5–4 Hz spike, polispike-wave pattern and brief trains of polispikes during confusional state (Fig. 1a). Intravenous (IV) diazepam (10 mg in bolus) induced a

* Corresponding author. Tel.: +39 0881/736125; fax: +39 0881/732553. E-mail address: [email protected] (G. d’Orsi).

rapid but transient effect (Fig. 1b), with ASE reappearing after 5 min. The administration of IV diazepam (10 mg bolus) was also repeated without effect. We therefore administered an IV loading dose of 200 mg LCM over a period of 15 min, through a peripheral line, diluted in 50 ml of normal saline. During and at the end of infusion, the clinical picture and EEG pattern were unchanged (Fig. 1c). After 10 min, an additional 200 mg of LCM was administered for 15 min without effect (Fig. 1d). No adverse effects were observed during the administration of LCM and no ECG and laboratory values-changes were documented. After 24 h the ASE spontaneously resolved. The patient was then given 2000 mg/day VPA and 100 mg/day LTG, while LEV was gradually discontinued. She has now been seizure-free during the 12 months of follow-up. Although the most commonly used bolus dose of LCM is 200– 400 mg over 3–5 min,1 the right dose and the infusion rate needs further clarification. We tried splitting the dose of LCM into two slow infusions of 200 mg to further evaluate the efficacy. Status epilepticus is considered aborted if ictal patterns cease within 20 min following treatment and remains suppressed for 40 min.2 Therefore, it is evident that LCM was not effective in our case. ASE is a form of non-convulsive status epilepticus characterized by ongoing or intermittent epileptic activity with behavioural and cognitive changes and occurs in idiopathic generalized epilepsy.3 ASE has also been evident in adults whose idiopathic generalized epilepsy persists into adulthood and can occur as a consequence of drug withdrawal or other external factors such as sleep deprivation, excessive alcohol intake, menstruation, fever and metabolic disturbances. Finally, inappropriate antiepileptic drugs (especially carbamazepine) can also result in typical or atypical ASE. The EEG demonstrates a pattern of prolonged generalized synchronous 3 Hz spike-wave complexes; however, if ASE continues for several hours or more, the frequency of spike-wave discharges decreases. Variable response of ASE occurs with IV benzodiazepines, while good control with adequate doses of anti-absence drugs, mainly VPA, has been documented. The mechanism underlying the generation of absence seizures is due to an oscillatory activity within a corticothalamic network that depends on GABAergic systems, but especially T-type calcium channels.4 Phenytoin (PHT) and carbamazepine (CBZ) inhibit voltage-gated sodium channels (VGSCs) at therapeutic concentrations and the attenuation of Na+ current is the main mechanism of their efficacy for the

1059-1311/$ – see front matter ß 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.


G. d’Orsi et al. / Seizure 23 (2014) 397–398

Fig. 1. Generalized polispike-and-wave pattern during patient’s confusional state (a). IV diazepam induced a transient effect (b), while IV LCM was not effective (c and d).

treatment of focal and generalized tonic–clonic seizures, but not against absence seizures. In fact, these drugs are ineffective in pentetrazol-treated rodents, a model used to identify drugs that are efficacious for absence seizures. LCM acts primarily by interfering with the slowly inactivating component of voltagegated sodium currents, without affecting the fast component that is targeted by traditional sodium channel blockers.1 Moreover, as with PHT and CBZ, previous experimental evidence in rodent models showed that LCM did not provide protection against seizures provoked by pentylenetetrazol,4 and no effect is observed on voltage-clamped Ca2+ channels (T-, L-, N- or P-type). Consistent with this data, our case confirms that LCM selectively targets VGSCs, showing efficacy for the treatment of focal and generalized tonic-clonic seizures, but not against absence seizures and ASE.

Conflicts of interest The authors declare that there are no conflicts of interest. References 1. Ho¨fler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia 2013;54:393–404. 2. Treiman DM, Meyers PD, Walton NY, Collins JF, Rowan AJ, Handforth A, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998;17(12):792–8. 339. 3. Treiman DM. Eletroclinical features of status epilepticus. J Clin Neurophysiol 1995;12(4):343–62. 4. Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M. Voltage-gate sodium channels as therapeutic targets in epilepsy and other neurological disorders. Lancet Neurol 2010;9:413–24.

Lacosamide in absence status epilepticus.

Lacosamide in absence status epilepticus. - PDF Download Free
763KB Sizes 1 Downloads 0 Views

Recommend Documents

Lacosamide in Pediatric Status Epilepticus.
Investigators from Baylor College of Medicine studied the efficacy of lacosamide in pediatric status epilepticus (SE).

Status epilepticus developing during lacosamide monotherapy.
Two cases with partial onset epilepsy who developed status epilepticus (SE) on lacosamide (LCM) monotherapy are reported. LCM is an effective adjunctive antiepileptic drug (AED) for partial-onset epilepsy and as infusion in SE. It has also shown effi

Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
Status epilepticus (SE) is considered a life-threatening medical emergency. First-line treatment with antiepileptic drugs (AEDs) consists of intravenous benzodiazepines followed by phenytoin. SE is considered refractory (RSE) when unresponsive to sta

Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy.
Cerebral venous thrombosis (CVT) is an uncommon cause of stroke, accounting to less than 1% of all strokes. We describe a pregnant woman with a massive CVT in early pregnancy, complicated by status epilepticus. The mother was treated with levetiracet

Status epilepticus and refractory status epilepticus management.
Status epilepticus (SE) describes persistent or recurring seizures without a return to baseline mental status and is a common neurologic emergency. SE can occur in the context of epilepsy or may be symptomatic of a wide range of underlying etiologies

Treatment of refractory simple partial status epilepticus by the addition of oral lacosamide in neurosurgical patients. Report of 3 cases.
Lacosamide is a new antiepileptic drug that has been successfully used for the treatment of partial seizures. We report three neurosurgical cases of simple partial status epilepticus refractory to multiple antiepileptic medications. The addition of o

Status Epilepticus in Children.
Status epilepticus (SE) is a life-threatening emergency that requires prompt treatment, including basic neuroresuscitation principles (the ABCs), antiepileptic drugs to stop the seizure and identification of etiology. It results from an inability to

Pediatric status epilepticus: how common is cerebrospinal fluid pleocytosis in the absence of infection?
To determine the rate of cerebrospinal fluid (CSF) pleocytosis among children presenting with status epilepticus (SE) without proven central nervous system infection.

Status epilepticus in adults.
Status epilepticus is a common neurological emergency with considerable associated health-care costs, morbidity, and mortality. The definition of status epilepticus as a prolonged seizure or a series of seizures with incomplete return to baseline is